Compare PCSA & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCSA | WKSP |
|---|---|---|
| Founded | 2011 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7M | 17.2M |
| IPO Year | N/A | N/A |
| Metric | PCSA | WKSP |
|---|---|---|
| Price | $0.27 | $2.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $1.00 | ★ $12.83 |
| AVG Volume (30 Days) | ★ 1.1M | 241.9K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $14,286,679.00 |
| Revenue This Year | N/A | $142.95 |
| Revenue Next Year | N/A | $109.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 123.37 |
| 52 Week Low | $0.15 | $1.92 |
| 52 Week High | $1.50 | $12.00 |
| Indicator | PCSA | WKSP |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 56.34 |
| Support Level | $0.27 | $2.47 |
| Resistance Level | $0.30 | $3.13 |
| Average True Range (ATR) | 0.02 | 0.23 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 62.34 | 80.51 |
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.